Eurofins Pharmaceutical Product Testing Belgium(SA)

BE 0435.237.515

Financial data from Eurofins Pharmaceutical Product Testing Belgium

	2023		2022		2021		2020
Profit/Loss Section 9904: Profit/Loss of the financial year (after taxes on result) (+/-)	€ 457.068	-44%	€ 822.735	64%	€ 502.697	40%	€ 360.339
Equity Section 10/15: Equity consists of capital, capital reserves and earnings that remain within the company. These are fully owned by the company and are at its disposal to cover its risks. The better the ratio between equity and debts, the more solvent a company is. A positive equity ratio is important. A negative equity ratio (because of accumulated losses) is a severe warning sign that the continuity of the company may be threatened.	€ 816.310	0%	€ 816.310	0%	€ 816.310	0%	€ 816.349
Gross margin Section 9900: Gross margin or added value is net sales minus the direct costs of the goods sold. In other words: sales invoices minus purchase invoices (70/74 – 60/61). A negative gross margin is a warning sign especially when occurring over several years. It may indicate that the company has insufficient means to cover internal costs like salaries, etc.	€ 3.052.096	15%	€ 2.644.363	33%	€ 1.994.483	13%	€ 1.760.842
Employees Section 9087: Average number of staff in full time equivalents	22,7	14%	19,9	4%	19,1	9%	17,6

Publications in the Belgian Official Journal from Eurofins Pharmaceutical Product Testing Belgium

	Date	Publication
	15-09-2023	Resignations - Appointments (NL)
	27-06-2022	Resignations - Appointments (NL)
	18-11-2021	Articles of Association (Translation, Coordination, Other Modifications, …) - Resignations - Appointments (NL)
	30-08-2021	Resignations - Appointments (NL)
	02-06-2021	Resignations - Appointments (NL)

Frequently asked questions

What is the VAT number of Eurofins Pharmaceutical Product Testing Belgium?

The VAT number of Eurofins Pharmaceutical Product Testing Belgium is BE0435237515.

When was Eurofins Pharmaceutical Product Testing Belgium founded?

Eurofins Pharmaceutical Product Testing Belgium was founded on 09-09-1988.

What is the address of Eurofins Pharmaceutical Product Testing Belgium?

The current registered office of Eurofins Pharmaceutical Product Testing Belgium is located at Lieven Bauwensstraat 6, 8200 Brugge.

When was the last time Eurofins Pharmaceutical Product Testing Belgium filed their annual financial statements?

The most recent financial statements of Eurofins Pharmaceutical Product Testing Belgium were filed on 11-07-2024. You can view them here.

How many employees does Eurofins Pharmaceutical Product Testing Belgium have?

There are 22,7 FTEs working at Eurofins Pharmaceutical Product Testing Belgium according to the staff figures in the most recent financial statements.

What is the annual turnover of Eurofins Pharmaceutical Product Testing Belgium?

At the time of its most recent financial statements, Eurofins Pharmaceutical Product Testing Belgium did not publish any turnover figures. Eurofins Pharmaceutical Product Testing Belgium reported a gross margin of €3,052,096.75.